Krzysztof Jamroziak

Functional C3435T polymorphism of <i>MDR1</i> gene: an impact on genetic susceptibility and clinical outcome of childhood acute lymphoblastic leukemia

Krzysztof Jamroziak, Wojciech Młynarski, Ewa Balcerczak et al. · European Journal Of Haematology · 2004 · 196 citations

Life Sciences, Genetics, Molecular Genetics +13

Comparison of Cladribine Plus Cyclophosphamide With Fludarabine Plus Cyclophosphamide As First-Line Therapy for Chronic Lymphocytic Leukemia: A Phase III Randomized Study by the Polish Adult Leukemia Group (PALG-CLL3 Study)

Tadeusz Robak, Krzysztof Jamroziak, Joanna Góra‐Tybor et al. · Journal of Clinical Oncology · 2010 · 99 citations · Full text

Medicine, Oncology, Pharmacology +16

<scp><i>TERT</i></scp> gene harbors multiple variants associated with pancreatic cancer susceptibility

Daniele Campa, Cosmeri Rizzato, Rachael Z. Stolzenberg‐Solomon et al. · International Journal of Cancer · 2015 · 77 citations

Medicine, Genetics, Molecular Genetics +16

Cladribine in a weekly versus daily schedule for untreated active hairy cell leukemia: final report from the Polish Adult Leukemia Group (PALG) of a prospective, randomized, multicenter trial

Tadeusz Robak, Krzysztof Jamroziak, Joanna Góra‐Tybor et al. · Blood · 2007 · 75 citations · Full text

Medicine, Oncology, Pharmacology +11

Carfilzomib, lenalidomide, and dexamethasone or lenalidomide alone as maintenance therapy after autologous stem-cell transplantation in patients with multiple myeloma (ATLAS): interim analysis of a randomised, open-label, phase 3 trial

Dominik Dytfeld, Tomasz Wróbel, Krzysztof Jamroziak et al. · The Lancet Oncology · 2023 · 74 citations · Full text

Medicine, Oncology, Pharmacotherapy +17